Embarking on a New Era of Immunotherapy for Proteinopathies

Time: 9:30 am
day: Day Two

Details:

  • Focusing on the evidence that antibodies can reduce extracellular and intraneuronal accumulation of protein aggregates and prevent neurodegeneration 
  • Reviewing the current clinical landscape of immunotherapeutics being tested in neurodegenerative diseases 

Speakers: